Back to 
STRS Ohio
STRS Ohio
BTAIQ
Showing 0 of 8 quarters
Position history for STRS Ohio's holdings in BioXcel Therapeutics, Inc.
No. STRS Ohio exited its BTAIQ (BioXcel Therapeutics) position in Q1 2021. Its Q4 2020 13F listed 4,000 shares worth $184,000. STRS Ohio first reported BTAIQ in Q2 2019 and held it in 7 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.